Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hartmut Grasemann (Toronto, Canada), Hartmut Grasemann, Tanja Gonska, Julie Avolio, Michelle Klingel, Elizabeth Tullis, Felix Ratjen. Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy. Eur Respir J 2015; 46: Suppl. 59, 1444

Member's Comments

No comment yet.

Related content which might interest you: Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001 Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016 Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006 Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Airway acidification and exhaled nitric oxide in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003 Reduced exhaled nitric oxide in infants with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Bronchial but not alveolar nitric oxide is decreased in adults with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019 Nasal nitric oxide measurement and a score of key clinical features for the screening of primary ciliary dyskinesia in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Source: Eur Respir J 2009; 34: 117-124 Year: 2009 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010 Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients Source: Eur Respir J 2009; 34: 138-144 Year: 2009 Orally and nasally exhaled nitric oxide and nitrite in asthmatic and cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013